A New Paradigm: Using PARP Inhibitors to Treat HER2+ Breast Cancer

Grant

Date/time Interval

  • August 1, 2018 - July 31, 2021
  • Total Award Amount

  • 450000.00
  • Direct Costs

  • 360000.00
  • Sponsor Award Id

  • CCR17483682
  • Contributor

  • Acosta Pharm.D., Edward   Investigator  
  • Stringer-Reasor M.D., Erica   Principal Investigator  
  • Yang M.D., Ph.D., Eddy   Investigator